CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Yscript develops a novel method for producing messenger RNA using yeast, aiming to simplify and reduce the costs of mRNA production for medical applications. This innovative approach enhances the purity and stability of mRNA, making it more accessible, especially for low-income countries.
Messenger RNA (mRNA) vaccines have become a game-changer in the fight against COVID-19, providing an exit strategy to the global crisis of our age. mRNA is now considered a promising biopharmaceutical for a vast array of medical applications.
Currently, in vitro transcription (IVT) is the only available technology for mRNA production; however, it relies on a complex supply chain and costly purification process.
Reliable large-scale IVT production is challenging and high production costs are an i…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 5 partners.
France, PARIS
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Portugal, Aveiro
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Portugal, Covilha
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
